SpiceJet signs MoU with PLUSS for COVID-19 vaccine delivery 

29 December 2020 | News

PLUSS will supply its patented product – Celsure® for transportation of the COVID-19 vaccines from the manufacturer to different parts of the country

Source credit: Shutterstock

Source credit: Shutterstock

SpiceJet has announced the signing of a Memorandum of Understanding (MoU) with Pluss Advanced Technologies (PLUSS) for the supply of indigenously developed precise temperature control boxes required of maintaining the effectiveness of the vaccine during transport.

According to the MoU, PLUSS will supply its patented product – Celsure®, developed using its proprietary Phase Change Material technology, for transportation of the COVID-19 vaccines from the manufacturer to different parts of the country. The product will be co-branded especially for SpiceJet’s cargo division Spice Xpress and will be made available at various locations across the country.

“We are particularly happy to join forces with SpiceJet to ensure the delivery of the vaccine using the safest and fastest mode. SpiceJet flies to many non-metro locations and that will help the vaccine reach to the rural hinterlands of India,” said Samit Jain, MD, PLUSS.

“We can cover the length and breadth of the country through our partnerships with last mile logistics companies. We can deliver the vaccines within 48-72 hours to any part of the country and Pluss’ temperature control boxes will play a critical role in ensuring the safety and efficacy of the vaccine” said Sanjiv Gupta, CEO, Spice Jet-Cargo Division.

PLUSS, funded by Tata Capital Innovation Fund, has made rapid strides in precise temperature control solutions using inhouse R&D and has several award-winning solutions and patents for pharma, building and logistics industries in India and overseas.    


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account